BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 23694789)

  • 21. The many faces of corticobasal degeneration.
    Wadia PM; Lang AE
    Parkinsonism Relat Disord; 2007; 13 Suppl 3():S336-40. PubMed ID: 18267261
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Subcortical dementia revisited: similarities and differences in cognitive function between progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and multiple system atrophy (MSA).
    Bak TH; Crawford LM; Hearn VC; Mathuranath PS; Hodges JR
    Neurocase; 2005 Aug; 11(4):268-73. PubMed ID: 16093227
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduction of neuromelanin-positive nigral volume in patients with MSA, PSP and CBD.
    Kashihara K; Shinya T; Higaki F
    Intern Med; 2011; 50(16):1683-7. PubMed ID: 21841326
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Neuropsychology (Broadly Conceived) of Multiple System Atrophy, Progressive Supranuclear Palsy, and Corticobasal Degeneration.
    Gerstenecker A
    Arch Clin Neuropsychol; 2017 Nov; 32(7):861-875. PubMed ID: 28961692
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cerebral glucose metabolism in corticobasal degeneration: comparison with progressive supranuclear palsy and normal controls.
    Nagahama Y; Fukuyama H; Turjanski N; Kennedy A; Yamauchi H; Ouchi Y; Kimura J; Brooks DJ; Shibasaki H
    Mov Disord; 1997 Sep; 12(5):691-6. PubMed ID: 9380049
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glucocerebrosidase mutations p.L444P and p.N370S are not associated with multisystem atrophy, progressive supranuclear palsy and corticobasal degeneration in Polish patients.
    Jamrozik Z; Lugowska A; Slawek J; Kwiecinski H
    J Neurol; 2010 Mar; 257(3):459-60. PubMed ID: 19882201
    [No Abstract]   [Full Text] [Related]  

  • 27. Associations of mitochondrial genomic variation with corticobasal degeneration, progressive supranuclear palsy, and neuropathological tau measures.
    Valentino RR; Tamvaka N; Heckman MG; Johnson PW; Soto-Beasley AI; Walton RL; Koga S; Uitti RJ; Wszolek ZK; Dickson DW; Ross OA
    Acta Neuropathol Commun; 2020 Sep; 8(1):162. PubMed ID: 32943110
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genome-wide association study of corticobasal degeneration identifies risk variants shared with progressive supranuclear palsy.
    Kouri N; Ross OA; Dombroski B; Younkin CS; Serie DJ; Soto-Ortolaza A; Baker M; Finch NCA; Yoon H; Kim J; Fujioka S; McLean CA; Ghetti B; Spina S; Cantwell LB; Farlow MR; Grafman J; Huey ED; Ryung Han M; Beecher S; Geller ET; Kretzschmar HA; Roeber S; Gearing M; Juncos JL; Vonsattel JPG; Van Deerlin VM; Grossman M; Hurtig HI; Gross RG; Arnold SE; Trojanowski JQ; Lee VM; Wenning GK; White CL; Höglinger GU; Müller U; Devlin B; Golbe LI; Crook J; Parisi JE; Boeve BF; Josephs KA; Wszolek ZK; Uitti RJ; Graff-Radford NR; Litvan I; Younkin SG; Wang LS; Ertekin-Taner N; Rademakers R; Hakonarsen H; Schellenberg GD; Dickson DW
    Nat Commun; 2015 Jun; 6():7247. PubMed ID: 26077951
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Glial abnormalities in progressive supranuclear palsy and corticobasal degeneration].
    Zhu MW; Wang LN; Li XH; Gui QP
    Zhonghua Bing Li Xue Za Zhi; 2004 Apr; 33(2):125-9. PubMed ID: 15132848
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diffusion tensor magnetic resonance imaging for single subject diagnosis in neurodegenerative diseases.
    Sajjadi SA; Acosta-Cabronero J; Patterson K; Diaz-de-Grenu LZ; Williams GB; Nestor PJ
    Brain; 2013 Jul; 136(Pt 7):2253-61. PubMed ID: 23729473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and pathologic evidence of corticobasal degeneration and progressive supranuclear palsy in familial tauopathy.
    Tuite PJ; Clark HB; Bergeron C; Bower M; St George-Hyslop P; Mateva V; Anderson J; Knopman DS
    Arch Neurol; 2005 Sep; 62(9):1453-7. PubMed ID: 16157754
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The diagnostic challenge of corticobasal degeneration: distinction between clinical syndrome and pathology].
    Kellner O; Sabova K; Neumann M; Jung HH
    Fortschr Neurol Psychiatr; 2011 Nov; 79(11):660-7. PubMed ID: 22009274
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Astrocytic plaques and tufts of abnormal fibers do not coexist in corticobasal degeneration and progressive supranuclear palsy.
    Komori T; Arai N; Oda M; Nakayama H; Mori H; Yagishita S; Takahashi T; Amano N; Murayama S; Murakami S; Shibata N; Kobayashi M; Sasaki S; Iwata M
    Acta Neuropathol; 1998 Oct; 96(4):401-8. PubMed ID: 9797005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Action and object naming in frontotemporal dementia, progressive supranuclear palsy, and corticobasal degeneration.
    Cotelli M; Borroni B; Manenti R; Alberici A; Calabria M; Agosti C; Arévalo A; Ginex V; Ortelli P; Binetti G; Zanetti O; Padovani A; Cappa SF
    Neuropsychology; 2006 Sep; 20(5):558-65. PubMed ID: 16938018
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cholinergic imaging in corticobasal syndrome, progressive supranuclear palsy and frontotemporal dementia.
    Hirano S; Shinotoh H; Shimada H; Aotsuka A; Tanaka N; Ota T; Sato K; Ito H; Kuwabara S; Fukushi K; Irie T; Suhara T
    Brain; 2010 Jul; 133(Pt 7):2058-68. PubMed ID: 20558417
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dual pathology of corticobasal degeneration and Parkinson's disease in a patient with clinical features of progressive supranuclear palsy.
    Mooney T; Tampiyappa A; Robertson T; Grimley R; Burke C; Ng K; Patrikios P
    Neurol India; 2011; 59(6):887-90. PubMed ID: 22234205
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early clinical features of patients with progressive supranuclear palsy with predominant cerebellar ataxia.
    Kanazawa M; Tada M; Onodera O; Takahashi H; Nishizawa M; Shimohata T
    Parkinsonism Relat Disord; 2013 Dec; 19(12):1149-51. PubMed ID: 23916652
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Orofacial apraxia in corticobasal degeneration, progressive supranuclear palsy, multiple system atrophy and Parkinson's disease.
    Ozsancak C; Auzou P; Dujardin K; Quinn N; Destée A
    J Neurol; 2004 Nov; 251(11):1317-23. PubMed ID: 15592726
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Corticobasal degeneration shares a common genetic background with progressive supranuclear palsy.
    Di Maria E; Tabaton M; Vigo T; Abbruzzese G; Bellone E; Donati C; Frasson E; Marchese R; Montagna P; Munoz DG; Pramstaller PP; Zanusso G; Ajmar F; Mandich P
    Ann Neurol; 2000 Mar; 47(3):374-7. PubMed ID: 10716259
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Corticobasal degeneration: an autopsy case clinically diagnosed as progressive supranuclear palsy.
    Shiozawa M; Fukutani Y; Sasaki K; Isaki K; Hamano T; Hirayama M; Imamura K; Mukai M; Arai N; Cairns NJ
    Clin Neuropathol; 2000; 19(4):192-9. PubMed ID: 10919351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.